What are Cumberland Pharmaceuticals's profit margins?

Cumberland Pharmaceuticals (CPIX) runs a 82.9% gross margin and a -17.2% operating margin, with a -17.6% net margin.

Where do Cumberland Pharmaceuticals's ratios come from?

Every ratio is computed from Cumberland Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Cumberland Pharmaceuticals CPIX Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Gross margin	85%+2.4pp	82.6%-2.1pp	84.7%+6.4pp	78.3%+2.8pp
Operating margin	-6.3%+10.7pp	-17%+7.2pp	-24.2%-10.6pp	-13.6%+7.8pp
Net margin	-6.4%+10.7pp	-17.1%-1.2pp	-15.9%-2.6pp	-13.3%-3.5pp
EBITDA margin	3%+7.1pp	-4%+7.6pp	-11.7%-10.8pp	-0.9%+7.6pp
Free cash flow margin	10.9%—	——	14.7%-5.2pp	19.9%+2.1pp
Returns
Return on equity	-11.9%+12.8pp	-24.7%-5.6pp	-19.1%-5.0pp	-14.1%-6.3pp
Return on assets	-3.7%+4.5pp	-8.2%-1.0pp	-7.2%-0.9pp	-6.3%-2.4pp
Return on invested capital	-16.6%+23.3pp	-39.9%+10.1pp	-50%-20.1pp	-29.9%+7.4pp
Efficiency
Asset turnover	0.6×+0.1×	0.5×0.0×	0.5×0.0×	0.5×+0.1×
Inventory turnover	0.7×+0.1×	0.6×0.0×	0.6×-0.5×	1.1×+0.2×
Liquidity
Current ratio	1×-0.1×	1.2×-0.1×	1.3×-0.3×	1.6×-0.8×
Quick ratio	0.8×0.0×	0.8×0.0×	0.8×-0.5×	1.3×-0.6×
Cash ratio	0.3×-0.3×	0.6×-0.1×	0.7×0.0×	0.7×-0.7×
Leverage
Debt-to-equity	0.2×-0.3×	0.5×+0.3×	0.2×+0.1×	0.1×+0.1×
Debt-to-assets	0.1×-0.1×	0.1×+0.1×	0.1×0.0×	0.1×0.0×
Net debt / EBITDA	-4.8×—	——	——	——
Interest coverage	-5.6×+5.0×	-10.6×+3.7×	-14.3×-4.6×	-9.7×+68.6×
Per Share
Book value per share	$1.67+3.0%	$1.63-21.5%	$2.07-16.9%	$2.49-13.3%
Valuation
Market capitalization	$97.09M+142%	$33.28M+31.3%	$25.35M-21.8%	$32.4M-52.8%
Enterprise value	$90.91M+212%	$25.71M+103%	$12.68M-27.2%	$17.4M-59.2%
Price / sales	2.3×+1.4×	0.9×+0.2×	0.6×-0.1×	0.8×-1.1×
Price / book	4.5×+3.1×	1.5×+0.6×	0.9×0.0×	0.9×-0.7×
EV / EBITDA	39.2×—	——	——	——
EV / sales	2.2×+1.5×	0.7×+0.4×	0.3×-0.1×	0.4×-0.8×
Free cash flow yield	1.4%—	——	22.9%-2.8pp	25.8%+16.4pp
Earnings yield	-7.6%-0.3pp	-19.5%+5.3pp	-24.8%-7.6pp	-17.2%-12.1pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Cumberland Pharmaceuticals.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Cumberland Pharmaceuticals's profit margins?: Cumberland Pharmaceuticals (CPIX) runs a 82.9% gross margin and a -17.2% operating margin, with a -17.6% net margin.
Where do Cumberland Pharmaceuticals's ratios come from?: Every ratio is computed from Cumberland Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.